SecBot SecBot
6-K ·Filed Nov 5, 2026

PASW

Ping An Biomedical Co., Ltd.
NEUTRAL
Impact 3/10
Horizonmonths Processed12d 8h ago SEC0001213900-26-116144
Notable filing: 6-K
Actionable Insight • Neutral

The $2.3M patent purchase is small relative to the $16M market cap but represents a meaningful cash outlay for a micro-cap apparel SCM company pivoting into biotech. Monitor closing conditions and any subsequent strategic investment in Future Biotechnology Group, which could be larger.

DirectionNeutral
Confidencemedium
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$1.59
T+0 close · Nov 5, 2026 · via day close
Latest settled
−1.57%
T+5 · $1.57
Vs SPY
−4.86%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $1.59entry
  2. T+1 · 11d ago −17.61%α −17.92% · $1.31
  3. T+5 · 5d ago −1.57%α −4.86% · $1.57
  4. T+8 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Ping An Biomedical entered a definitive agreement to acquire three tumor cell-related medical technology patents from Future Biotechnology Group for $2.3 million. The acquisition is positioned as a long-term capacity-building move, not a near-term revenue driver, and the company continues to advance negotiations for a strategic investment in the seller.

Key Facts

  • Definitive purchase agreement for three tumor cell-related patents at $2.3 million
  • Patents cover oncology diagnosis/treatment, cell detection/bioengineering, biomarker/DNA probe technologies
  • Company states the acquisition is not a near-term revenue driver but a capacity-building move
  • Separately, negotiations continue for a proposed strategic investment in Future Biotechnology Group
  • Company's primary business is apparel supply chain management; healthcare/biomedical is a newer strategic direction

Financial Impact

Cash consideration of $2.3 million; represents ~14% of $16M market cap

cashintangible assets

Risk Factors

  • No near-term revenue expected from the acquired patents; commercialization path is staged and subject to regulatory approvals
  • Company's primary business is apparel SCM, not biotech; execution risk in a new technology area
  • Cash burn risk: $2.3M is material for a $16M market cap company

Market Snapshot

Exchange
Nasdaq
Sector
Apparel & Other Finishd Prods of Fabrics & Similar Matl

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-116144
Document: ea0311054-6k_pingan.htm0001213900-26-116144
Document: 0001213900-26-116144-index-headers.html0001213900-26-116144
Document: 0001213900-26-116144-index.html0001213900-26-116144
Document: 0001213900-26-116144.txt0001213900-26-116144
Earnings Context (Synthetic; results releases only)0001213900-26-116144

Track record

12 reports on PASW

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +71.15% at T+5 after the Oct 30, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 17, 2026today 6-K Neutral 4/10 Entry $1.41 Now $1.44 +1.94% settles Nov 19
  2. Nov 12, 20265d ago EFFECT Neutral 3/10 Entry $1.57 to $1.53 Now $1.44 −7.99% ▼ −2.24% −1.87% vs SPY
  3. Nov 5, 202612d ago 6-K Neutral 3/10 Viewing Entry $1.59 to $1.31 Now $1.44 −9.43% ▼ −17.61% −17.92% vs SPY
  4. Oct 30, 202618d ago 6-K Bearish 6/10 Entry $4.68 to $4.96 Now $1.44 +69.23% ▼ −5.98% −5.68% vs SPY
  5. Oct 26, 202622d ago 6-K Neutral 4/10 Entry $4.48 to $4.88 Now $1.44 −67.86% ▲ +8.93% +8.37% vs SPY
  6. Oct 22, 202626d ago 6-K Bearish 5/10 Entry $4.76 to $4.48 Now $1.44 +69.75% ▲ +5.88% +6.59% vs SPY
  7. Oct 22, 202626d ago Press Release Neutral 3/10 Entry $0.1340 to $0.1190 Now $1.44 +974.63% ▼ −11.19% −10.67% vs SPY
  8. Oct 21, 202627d ago 6-K Neutral 3/10 Entry $3.68 to $5.40 Now $1.44 −60.87% ▲ +46.85% +48.03% vs SPY
  9. Sep 11, 20269w ago 6-K Bearish 6/10 Entry $0.1380 to $0.1367 Now $1.44 −943.48% ▲ +0.94% +0.50% vs SPY
  10. Jul 20, 202617w ago 6-K Neutral 4/10 Entry $0.1459 to $0.1467 Now $1.44 +886.98% ▲ +0.55% −0.29% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Wed (16h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026